Skip to main content
Elsevier

Advances in Immunology in China - Part B

  • 1st Edition, Volume 145 - February 18, 2020
  • Latest edition
  • Editors: Chen Dong, Zhengfan Jiang
  • Language: English

Advances in Immunology in China - Part B, Volume 145, the latest release in the Advances in Immunology series, presents the latest release in a long-established and highly respe… Read more

Description

Advances in Immunology in China - Part B, Volume 145, the latest release in the Advances in Immunology series, presents the latest release in a long-established and highly respected publication. The book includes current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this release focusing on advances in immunology in China.

Key features

  • Presents current developments and comprehensive reviews in immunology
  • Provides the latest in a longstanding, respected serial on the subject matter
  • Focuses on recent advances in the advancing area of Advances in Immunology in China

Readership

Immunologists and infectious disease specialists, cell biologists and hematologists

Table of contents

1. Deciphering the pathways to antiviral innate immunity and inflammation
Qing Yang and Hong-Bing Shu

2. Tissue-resident NK cells and other innate lymphoid cells
Jing Zhou, Zhigang Tian and Hui Peng

3. The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases
Hua Jiang, Tao Gong and Rongbin Zhou

4. Fine-tuning of antiviral innate immunity by ubiquitination
Yi Zheng and Chengjiang Gao

5. Metabolic regulation of innate immunity
Shaonan Liang, Liangliang Ji, Lan Kang and Xiaoyu Hu

6. Regulation of MHC class I-independent NK cell education by SLAM family receptors
Shasha Chen, Dan Li, Yuande Wang, Qiaozhen Li and Zhongjun Dong

7. Metalloimmunology: The metal ion-controlled immunity
Chenguang Wang, Rui Zhang, Xiaoming Wei, Mengze Lv and Zhengfan Jiang

Product details

  • Edition: 1
  • Latest edition
  • Volume: 145
  • Published: February 18, 2020
  • Language: English

About the editors

CD

Chen Dong

Chen Dong is at Tsinghua University, Beijing, China
Affiliations and expertise
Tsinghua University, Beijing, China

ZJ

Zhengfan Jiang

Zhengfan Jiang is a Peking-Tsinghua Center for Life Sciences (CLS) Investigator, a tenured full professor and Vice Dean of the School of Life Sciences (SLS) at Peking University (PKU). He works on innate immunity and related cell signaling and, more specifically, on the molecular mechanisms of host defense against virus infection. His lab has identified ERIS which is also named STING and MITA and provided molecular insights into the coordination among viral infection-induced cytokine production, inflammation and apoptosis. Recently, his lab has identified Mn2+ as a critical component required for antiviral innate immunity by activating the cGAS-STING pathway. He has been honored to the National Science Foundation for Distinguished Young Scholars, China and the Cheung Kong Scholar and tenured full professor at PKU.
Affiliations and expertise
School of Life Sciences, Peking University, Beijing, China

View book on ScienceDirect

Read Advances in Immunology in China - Part B on ScienceDirect